Deaths and necropsies evaluation in hospitalized patients of a Pediatric Rheumatology Unit for a period of ten years;Avaliação dos óbitos e necropsias em pacientes internados em um Serviço de Reumatologia Pediátrica por um período de dez anos

Revista Brasileira de Reumatologia

Volumn 45, Issue 2, 2005, Pages 55-63

  Facó, Mércia Moreira ^a   Nukumizu, Lucia Akemi ^a   De Moraes, Ana Júlia Pantoja ^a   Barros, Paula Cruz Borreli ^a   Troster, Eduardo Juan ^a   Da Silva, Clovis Artur Almeida ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FMUSP ^*  (Brazil)

Author keywords

Juvenile idiopathic arthritis; Juvenile systemic lupus erithematosus; Mortality; Necropsy; Pediatric rheumatology

Indexed keywords

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULONEPHRITIS; HEART INFARCTION; HODGKIN DISEASE; HOSPITAL PATIENT; HUMAN; IDIOPATHIC DISEASE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; PEDIATRIC WARD; SEPTICEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS;

EID: 33645525786     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042005000200003     Document Type: Article

References (49)

1. Ward MM, Pyun E, Studenski S: Causes of death in systemic lupus erythematosus: Long-term follow-up of an inception cohort. Artritis Rheum 38: 1492-9, 1995.
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J: Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22: 1259-64, 1995.
3. Singh S, Devidayal, Kumar L, Joshi K: Mortality patterns in childhood lupus-10 years experience in a developing country. Clin Rheumatol 21: 462-5, 2002.
4. Urowitz MB, Gladman DD: How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology 39: 238-44, 2000.
5. Hochberg MC: Updating the American College of Rheumathology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.
6. Masi AJ, Hunder GG, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome. Arthritis Rheum 33: 1094, 1990.
7. Bohan A, Peter JB: Polymyositis and dermatomyositis. N Engl J Med 292: 344-403, 1975.
8. Petty RE, Southwood TR, Manners P, et al: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31: 390-2, 2004.
9. Weening JJ, D'Agati VD, Schwartz MM, et al: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65: 521-30, 2004.
10. Bombardier C, Gladman DD, Urowitz MB, Karon D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-40, 1992.
11. Barr SG, Zonana-Nacach A, Magder LS, Petri M: Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 42: 2682-8, 1999.
12. Gladman D, Ginzler E, Goldsmith C, et al: The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39: 363-9, 1996.
13. Hanson V, Kornreich H, Bernstein B, King KK, Singsen BH: Prognosis of juvenile rheumatoid arthritis. Arthritis Rheum (Supllement) 20: 279-84, 1977.
14. Ramos SR. Epidemiologia das Infecções Hospitalares em Pediatria. In: Marcondes E, Vaz AC, Ramos JL, Okay Y: Pediatria Básica - Tomo II, 9.a ed, São Paulo, Sarvier, 2003, p. 92-5.
15. Macperson TA, Stocker JT. The pediatric autopsy. In: Stocker JT, Dehner LP. Pediatric Pathology, Philadelphia, Lippincott Williams e Wilkins, 1992, p. 3-14.
16. Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann M, Weisberg RN: The value of the autopsy in three medical eras. N Engl J Med 308: 1000-5, 1983.
17. Jacobsen S, Petersen J, Ullman S, et al: Mortality and causes of death of 513 danish patients with systemic lupus erythematosus. Scand J Rheumatol 28: 75-80, 1990.
18. Bethany AD, Lori BT, Laurie CM, et al: Demography of a Regional Pediatric Rheumatology Patient Population. J Rheumatol 21: 1553-7, 1994.
19. Erdes SH, Demina AB, Folomeeva OM, Radenska-Lopovok SG, Zairatiants OV: Analysis of lethal outcomes of rheumatic disease in Moscow. Ter Arkh 75: 78-82, 2003.
20. Lacks S, White S: Morbidity associated whit childhood systemic lupus erythematosus. J Rheumatol 17: 941-5, 1990.
21. Pizzo PA: Fever in the immunocompromissed patients. N Engl J Med 341: 893-900, 1999.
22. Petri M: Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 24: 423-56, 1998.
23. Len CA, Terreri MT, Hilário MOE: Lúpus eritematoso sistêmico juvenil e infecção. Rev Bras Reumatol 42: 218-22, 2002.
24. Cassidy JT, Sullivan DB, Petty RL, Rogsdale C: Lupus nephritis and encephalopathy. Prognosis in 58 children. Arthritis Rheum 20: 315-22, 1977.
25. Lee BW, Yap HK, Yip YC: A 10 years review of systemic lupus erythematosus in Singapore children. Aust Pediatr J 23: 163-5, 1987.
26. Baum J, Gutowska G: Death in juvenile rheumatoid arthritis. Arthritis Rheum (Supplement) 20: 253-5, 1977.
27. Minaen K, Nierwerth M, Listing J, et al: Long-term outcome in patients with juvenile idiopatic arthritis. Arthritis Rheum 46: 2392-401, 2002.
28. Bernstein B: Death in juvenile rheumatoid arthritis. Arthritis Rheum (Supplement) 20: 256, 1977.
29. Boone JE: Hepatic disease and mortality in juvenile rheumatoid arthritis. Arthritis Rheum (Supplement) 20: 257-9, 1977.
30. Grom AA, Passo M: Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. J Pediat 129: 630-2, 1996.
31. Ravelli A: Macrophage activation syndrome. Curr Opin Rheumatol 14: 548-52, 2002.
32. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM: Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatol 40: 1285-92, 2001.
33. Stephan JL, Zeller J, Hulert P, et al: Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases. Clin Exp Rheumatol 11: 451-6, 1993.
34. Aran BM, Perez G, Rosell J, Molina P: Exactness of mortality statistics by external and natural cause of death with medico-legal intervention in Catalônia. Gac Sanit 14: 356-62, 2000.
35. Suzuki A, Ohosone Y, Obana M, et al: Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21: 33-6, 1994.
36. Iriya SM, Capelozzi VL, Calich I, Martins MA, Lichtenstein A: Causes of death in Patients With Systemic Lupus Erythematosus in São Paulo, Brazil: A Study of 113 Autopsies. Arch Intern Med 161: 1557-60, 2001.
37. Hunt R, Barr P: Errors in the certification of neonatal death. J Paediatr Child Health 36: 498-501, 2000.
38. Hatton F, Bouvier-Colle MH, Barois A, et al: Autopsies of sudden infant death syndrome-classification and epidemiology. Acta Paediatr 84: 1366-71, 1995.
39. Cardoso MP: Concordância entre diagnóstico clínico e achados de autópsias em unidade de terapia intensiva pediátrica. Dissertação de Mestrado. Faculdade de Medicina da Universidade de São Paulo, 2000.
40. Manzi S, Meilahn EN, Raine JE, et al: Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Frammingham cohort. Am J Epidemol 145: 408-415, 1997.
41. Dória A, Shoenfeld Y, Wu R, et al: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62: 1071-7, 2003.
42. Canova EG, Rosa DC, Vallada MG, Silva CA: Invasive aspergillosis in juvenile systemic lupus erythematosus. A clinico-pathologic case. Clin Exp Rheumatol 20: 736, 2002.
43. Pryor BD, Bologna SG, Kahl LE: Risk factors for serious infection during treatment with cyclophosphamide and high dose of corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39: 1475-82, 1996.
44. Ruben LA, Urowitz MB, Gladman DD: Mortality in systemic lupus erythematosus: The modal pattern revisited. Q J Med 55: 87-98, 1985.
45. Cleary AG, McDowell H, Sills JA: Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child 86: 47-9, 2002.
46. Lampert F, Belohradsky BH, Forster C: Infantile chronic relapsing inflammation of the brain, skin and joints. Lancet 1: 1250, 1975.
47. Fajardo JE, Geller TJ, Koenig HN: Chronic meningitis, polyarthritis, lymphadenitis and pulmonary hemosiderosis. J Pediatr 101: 738, 1982.
48. Prieur AM, Griscelli C, Lampert F: A chronic, infantile, neurological cutaneous and articular (CINCA) syndrome. A specific entity analyzed in 30 patients. Scand J Rheumatol 66: 57, 1987.
49. Cassidy JT, Petty RE: Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE: Textbook of Pediatric Rheumatology, 4 ed, Philadelphia, WB Saunders Company, 2001, p. 218-321.